The Sunday Times Features Luxury Fertility Concierge IMA ART's Co-Founders Michelle Tang & Ron Sonnenberg
The Feature Article, written by Megan Agnew, highlights IMA ART's transformative approach to Luxury Fertility & Surrogacy for Discerning Clientele.
BEVERLY HILLS, CA / ACCESSWIRE / September 17, 2024 / IMA ART, the world's premier luxury fertility concierge, was recently featured in The Sunday Times Magazine. The article, titled "Want a Girl with Blue Eyes? Inside California's VIP IVF Industry," was published on September 15, 2024, and offers an exclusive glimpse into the extraordinary services provided by IMA ART's co-founders, Michelle Tang and Ron Sonnenberg, for discerning clientele of ultra-high-net-worth individuals.
Photo of Co-Founders Michelle Tang and Ron Sonnenberg
Megan Agnew's feature underscores IMA ART's revolutionary bespoke approach to fertility and surrogacy, spotlighting the boutique white-glove fertility concierge offered to the select few who engage their services. As the only Fertility Maison, IMA ART limits its annual clientele, meticulously curating every aspect of the fertility concierge and surrogacy process, from selecting Reproductive Endocrinologists and private nurses, to designing a personalized experience for each client. Every aspect of their clients' arrival in Los Angeles, from exclusive dining reservations and luxury accommodations to seamless transportation, are meticulously curated.
During the interview, Tang and Sonnenberg emphasized the rigorous selection process for surrogates, ensuring not only their physical well-being but also the safety and environment in which they live. "We assess everything, from cleanliness to the neighborhood," Sonnenberg shared. Once a match is made, IMA ART customizes every element of the surrogacy arrangement, from diet and lifestyle preferences to home care, ensuring optimal conditions for both surrogate and baby.
The article also touches on IMA ART's full-service, white-glove approach, from providing private medical consultations to scheduling appointments with Beverly Hills' top fertility clinics. IMA ART's concierge service, ranging from $30,000 to $85,000+ offers unmatched support and guidance, ensuring that every detail is handled with discretion and precision.
Michelle Tang adds, "Our clients expect the highest level of care and detail, and that's exactly what we provide, from the beginning of the journey to the birth of their child." As a testament to their commitment, the firm provides surrogates with housekeepers, random alcohol testing upon client request, and even organizes "twin" births through coordinated surrogate pregnancies.
IMA ART's presence in the fertility space redefines luxury fertility & surrogacy, seamlessly blending privacy, exclusivity, and exceptional service.
About IMA ART
The World's First & Only White-Glove Luxury Fertility Concierge & Surrogacy Agency, nestled in the heart of Beverly Hills. The private firm is a sanctuary of bespoke advisory services offering discreet fertility solutions to an exclusive clientele. The Fertility Maison has redefined the journey for discerning clients expecting savoir-faire of excellence.
Known for its luxurious approach & strict confidentiality, it stands as a paradigm shift in Haute Fertility.
Contact Information
Ron Sonnenberg
Co-Founder
ron@imaartfertility.com
(424)-284-1408
SOURCE: IMA ART
View the original press release on newswire.com.
IMAART LLC

Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
SK tes Launches New Circular IT Facility in Shannon, Expanding Ireland’s Role in Global Sustainable Tech Services24.4.2025 09:30:00 CEST | Press release
SHANNON, IE / ACCESS Newswire / April 24, 2025 / SK tes, a global leader in sustainable IT asset disposition (ITAD) and technology lifecycle services, has announced plans to open a new 36,000 square foot purpose-built facility in Shannon, marking a major vote of confidence in Ireland's thriving data and technology sector. The new facility will deliver comprehensive ITAD, data center decommissioning, and technology lifecycle management services to some of Ireland's largest enterprises, including hyperscale data center operators, while supporting national sustainability and circular economy goals. It will also create over 25 skilled jobs in one of the country's fastest-growing tech regions. "Ireland is at the forefront of Europe's digital economy, and our investment in Shannon reinforces our commitment to helping Irish companies manage technology securely, sustainably, and at scale," said Eric Ingebretsen, Chief Commercial Officer at SK tes. "This facility will allow us to meet the uniqu
Sauce Labs Launches Industry-First Enterprise Scale iOS 18 Testing on Sauce Labs Virtual Device Cloud, Boosting Test Speeds up to 40%24.4.2025 08:00:00 CEST | Press release
Leading test automation platform, powering development for over 300,000 active users and having executed more than 8 billion tests, enables developers and QA teams to ensure app quality on Apple's latest OS with unprecedented performance and scale. SAN FRANCISCO, CA / ACCESS Newswire / April 24, 2025 / Sauce Labs Inc., the leading platform for continuous quality, trusted by dev teams around the world to deliver apps users love, today announced the general availability of iOS 18 testing on its Virtual Device Cloud (VDC). Leveraging its new, high-performance Apple Silicon cloud infrastructure, Sauce Labs offers the market's most scalable enterprise-ready solution for automated mobile app and web testing on iOS 17.5, iOS 18, and beyond, enabling teams to execute tests up to 40% faster compared to previous versions. This launch addresses the critical need for timely testing support driven by Apple's transition to its proprietary Apple Silicon architecture and the rapid adoption rate of new
Introducing NUGEN(R) HLD-CD by Arxada: A Game-Changer in Healthcare Disinfection24.4.2025 07:00:00 CEST | Press release
Delivering Effective Germ Control in Five Minutes BASEL, CH / ACCESS Newswire / April 24, 2025 / Arxada, a global leader in specialty chemicals and innovative solutions, announces the launch of NUGEN® HLD-CD, a revolutionary healthcare disinfectant. This game-changing solution disinfects medical devices in just five minutes, ensuring that even the most resilient microorganisms, which can withstand harsh conditions, are destroyed.* NUGEN® HLD-CD is designed to meet the rigorous demands of healthcare environments. Its broad efficacy spectrum and short contact times make it suitable for all critical areas, including operating rooms, isolation areas, and intensive care units where speed and safety are essential. "We are excited to introduce NUGEN® HLD-CD to the healthcare market," said Uwe Holland, Head of Professional Hygiene EMEA at Arxada. "This solution is a game-changer in disinfection technology for healthcare facilities, providing professionals with a powerful means to improve patie
TCL Introduces the TCL T6C-UK Fire TV Series with QLED 4K, HDR PRO, and Freely23.4.2025 07:30:00 CEST | Press release
LONDON, UNITED KINGDOM / ACCESS Newswire / April 23, 2025 / TCL, the leading consumer electronics brand and the world's second-largest TV brand as well as an official sponsor of the Olympic Games, is proud to announce the launch of its highly anticipated T6C-UK TV series. The new range offers screen sizes from 43" to 85", ensuring there is a perfect option for every home. Featuring QLED technology, 4K resolution, and an intuitive Fire TV experience, the T6C-UK series offers exceptional picture quality, seamless content access, and smart functionality. The TCL T6C-UK series comes Freely-enabled, offering a seamless way to enjoy live and on-demand TV - all in one place and completely free. With Freely built-in, users can access their favourite streaming apps at the click of a button, eliminating the need to switch between platforms. From major channels to must-watch shows, everything is easily accessible from a single, intuitive home screen. Powered by Fire TV, the T6C-UK series also fea
BioNxt Solutions Prepares for Human Bioequivalence Study For MS23.4.2025 03:05:00 CEST | Press release
VANCOUVER, BC / ACCESS Newswire / April 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to report advanced preparation for its human bioequivalence study for its lead Multiple Sclerosis (MS) treatment. BioNxt's lead product, BNT23001, is a proprietary sublingual thin-film formulation of Cladribine for the treatment of MS. Preclinical studies, as reported in internal research data and third-party evaluations, have demonstrated high absorption rates and bioequivalence compared to existing oral tablet therapies. The Company has purchased Cladribine active pharmaceutical ingredient which is necessary to complete the technology transfer process with Gen-Plus, its European Contract Research and Development Organization (CRDO), in Munich, Germany. Once commenced, the bioequivalence study is relatively short, scheduled for less than 30 days from start to finish. T
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom